Rituximab Maintenance Treatment for a Maximum of 5 Years in Follicular Lymphoma: Final Results of the Randomized Phase III Trial SAKK 35/03Christian Taverna, Michele Ghielmini, Felicitas Hitz et al.|Blood|2018Cited by 1